In the Phase I/II KRYSTAL-1 study, Krazati plus cetuximab elicited a confirmed overall response rate of 34%, all of which were partial responses, meeting the primary endpoint, according to BMS
Our providers will schedule regular follow-ups to monitor your progress, address any questions, and adjust your care plan as needed to ensure your safety and success
Product suggestions will be solicited from CL members in July.) Clinical Update 7/29/2025 Metals in Plant-Based Protein Plant-based protein powders tend to contain higher amounts of lead and cadmium than whey-based products, according to a recent study
Here are steps you can take to limit your exposure to heavy metals: Filter your air Mercury can be in the air near coal-burning plants
People with health insurance through a government-funded plan, such as Medicare or Medicaid, arent eligible
More than half of semaglutide users experience minimal to no nausea, especially when following proper dose escalation protocols